HEICO CORP — Financial Data
Annual figures from SEC EDGAR XBRL filings (10-K)
These figures are extracted directly from XBRL-tagged financial statements that HEICO CORP filed with the SEC as part of its annual 10-K reports. XBRL (eXtensible Business Reporting Language) is a structured data format the SEC requires for machine-readable financial disclosures. Values shown are as reported — negative figures indicate a loss and are shown in red.
Revenue
Total revenue from all business activities — the top line of the income statement. Represents all money earned before any expenses are deducted.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Oct 31, 2025 | $4.49B | Dec 22, 2025 |
| FY2025 | Oct 31, 2024 | $3.86B | Dec 22, 2025 |
| FY2025 | Oct 31, 2023 | $2.97B | Dec 22, 2025 |
| FY2024 | Oct 31, 2022 | $2.21B | Dec 19, 2024 |
| FY2023 | Oct 31, 2021 | $1.87B | Dec 20, 2023 |
| FY2020 | Oct 31, 2020 | $426.18M | Dec 23, 2020 |
| FY2020 | Jul 31, 2020 | $386.41M | Dec 23, 2020 |
| FY2020 | Apr 30, 2020 | $468.15M | Dec 23, 2020 |
| FY2020 | Jan 31, 2020 | $506.28M | Dec 23, 2020 |
| FY2020 | Oct 31, 2019 | $541.53M | Dec 23, 2020 |
Revenue
Revenue recognized from contracts with customers under ASC 606, excluding taxes collected on behalf of government authorities. This is the primary revenue concept for many companies.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Oct 31, 2025 | $4.49B | Dec 22, 2025 |
| FY2025 | Oct 31, 2024 | $3.86B | Dec 22, 2025 |
| FY2025 | Oct 31, 2023 | $2.97B | Dec 22, 2025 |
| FY2024 | Oct 31, 2022 | $2.21B | Dec 19, 2024 |
| FY2023 | Oct 31, 2021 | $1.87B | Dec 20, 2023 |
| FY2022 | Oct 31, 2020 | $1.79B | Dec 21, 2022 |
| FY2021 | Oct 31, 2019 | $2.06B | Dec 21, 2021 |
| FY2020 | Oct 31, 2018 | $1.78B | Dec 23, 2020 |
| FY2019 | Oct 31, 2017 | $1.52B | Dec 19, 2019 |
Revenue (Net Sales)
Net sales revenue — gross revenue less returns, allowances, and discounts. Used by many manufacturers and retailers as the primary top-line figure.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2017 | Oct 31, 2017 | $421.22M | Dec 21, 2017 |
| FY2017 | Jul 31, 2017 | $391.50M | Dec 21, 2017 |
| FY2017 | Apr 30, 2017 | $368.66M | Dec 21, 2017 |
| FY2017 | Jan 31, 2017 | $343.43M | Dec 21, 2017 |
| FY2017 | Oct 31, 2016 | $363.30M | Dec 21, 2017 |
| FY2017 | Jul 31, 2016 | $356.08M | Dec 21, 2017 |
| FY2017 | Apr 30, 2016 | $350.65M | Dec 21, 2017 |
| FY2017 | Jan 31, 2016 | $306.23M | Dec 21, 2017 |
| FY2016 | Oct 31, 2015 | $328.67M | Dec 15, 2016 |
| FY2016 | Jul 31, 2015 | $300.37M | Dec 15, 2016 |
Gross Profit
Revenue minus the cost of goods sold (COGS). Gross profit shows how much revenue remains to cover operating expenses, R&D, and administrative costs before calculating operating income.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2020 | Oct 31, 2020 | $161.71M | Dec 23, 2020 |
| FY2020 | Jul 31, 2020 | $143.48M | Dec 23, 2020 |
| FY2020 | Apr 30, 2020 | $178.89M | Dec 23, 2020 |
| FY2020 | Jan 31, 2020 | $198.05M | Dec 23, 2020 |
| FY2019 | Oct 31, 2019 | $209.39M | Dec 19, 2019 |
| FY2019 | Jul 31, 2019 | $212.83M | Dec 19, 2019 |
| FY2019 | Apr 30, 2019 | $209.39M | Dec 19, 2019 |
| FY2019 | Jan 31, 2019 | $182.24M | Dec 19, 2019 |
| FY2018 | Oct 31, 2018 | $186.46M | Dec 20, 2018 |
| FY2018 | Jul 31, 2018 | $181.61M | Dec 20, 2018 |
Net Income
The bottom-line profit — what remains after all operating expenses, interest, taxes, and other costs are deducted. A negative value means the company reported a net loss for the year.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Oct 31, 2025 | $690.39M | Dec 22, 2025 |
| FY2025 | Oct 31, 2024 | $514.11M | Dec 22, 2025 |
| FY2025 | Oct 31, 2023 | $403.60M | Dec 22, 2025 |
| FY2024 | Oct 31, 2022 | $351.68M | Dec 19, 2024 |
| FY2023 | Oct 31, 2021 | $304.22M | Dec 20, 2023 |
| FY2020 | Oct 31, 2020 | $62.33M | Dec 23, 2020 |
| FY2020 | Jul 31, 2020 | $54.32M | Dec 23, 2020 |
| FY2020 | Apr 30, 2020 | $75.45M | Dec 23, 2020 |
| FY2020 | Jan 31, 2020 | $121.89M | Dec 23, 2020 |
| FY2020 | Oct 31, 2019 | $85.68M | Dec 23, 2020 |
Operating Income
Profit from core business operations before interest expense and income taxes (also known as EBIT). Excludes non-operating items, making it a cleaner measure of operational efficiency than net income.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Oct 31, 2025 | $1.02B | Dec 22, 2025 |
| FY2025 | Oct 31, 2024 | $824.46M | Dec 22, 2025 |
| FY2025 | Oct 31, 2023 | $625.34M | Dec 22, 2025 |
| FY2024 | Oct 31, 2022 | $496.84M | Dec 19, 2024 |
| FY2023 | Oct 31, 2021 | $392.90M | Dec 20, 2023 |
| FY2022 | Oct 31, 2020 | $376.65M | Dec 21, 2022 |
| FY2021 | Oct 31, 2019 | $457.10M | Dec 21, 2021 |
| FY2020 | Oct 31, 2018 | $376.25M | Dec 23, 2020 |
| FY2019 | Oct 31, 2017 | $306.66M | Dec 19, 2019 |
| FY2018 | Oct 31, 2016 | $265.35M | Dec 20, 2018 |
R&D Expense
Spending on research and development activities — developing new products, improving existing ones, or conducting basic research. High R&D relative to revenue is common in technology and pharmaceutical companies.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Oct 31, 2025 | $120.94M | Dec 22, 2025 |
| FY2025 | Oct 31, 2024 | $111.27M | Dec 22, 2025 |
| FY2025 | Oct 31, 2023 | $95.77M | Dec 22, 2025 |
| FY2024 | Oct 31, 2022 | $76.06M | Dec 19, 2024 |
| FY2023 | Oct 31, 2021 | $68.88M | Dec 20, 2023 |
| FY2022 | Oct 31, 2020 | $65.56M | Dec 21, 2022 |
| FY2021 | Oct 31, 2019 | $66.63M | Dec 21, 2021 |
| FY2020 | Oct 31, 2018 | $57.45M | Dec 23, 2020 |
| FY2019 | Oct 31, 2017 | $46.47M | Dec 19, 2019 |
| FY2018 | Oct 31, 2016 | $44.73M | Dec 20, 2018 |
SG&A Expense
Selling, general, and administrative expenses — the overhead costs of running the business, including salaries, marketing, legal fees, and corporate office costs. Excludes COGS and R&D.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Oct 31, 2025 | $767.47M | Dec 22, 2025 |
| FY2025 | Oct 31, 2024 | $677.27M | Dec 22, 2025 |
| FY2025 | Oct 31, 2023 | $528.15M | Dec 22, 2025 |
| FY2024 | Oct 31, 2022 | $365.92M | Dec 19, 2024 |
| FY2023 | Oct 31, 2021 | $334.52M | Dec 20, 2023 |
| FY2022 | Oct 31, 2020 | $305.48M | Dec 21, 2022 |
| FY2021 | Oct 31, 2019 | $356.74M | Dec 21, 2021 |
| FY2020 | Oct 31, 2018 | $314.47M | Dec 23, 2020 |
| FY2019 | Oct 31, 2017 | $268.07M | Dec 19, 2019 |
| FY2018 | Oct 31, 2016 | $250.15M | Dec 20, 2018 |
Operating Cash Flow
Cash generated from core business operations — a more reliable measure of financial health than net income because it strips out non-cash items like depreciation and one-time charges.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Oct 31, 2025 | $934.27M | Dec 22, 2025 |
| FY2025 | Oct 31, 2024 | $672.37M | Dec 22, 2025 |
| FY2025 | Oct 31, 2023 | $448.74M | Dec 22, 2025 |
| FY2024 | Oct 31, 2022 | $467.86M | Dec 19, 2024 |
| FY2023 | Oct 31, 2021 | $444.08M | Dec 20, 2023 |
| FY2022 | Oct 31, 2020 | $409.13M | Dec 21, 2022 |
| FY2021 | Oct 31, 2019 | $437.38M | Dec 21, 2021 |
| FY2020 | Oct 31, 2018 | $328.49M | Dec 23, 2020 |
| FY2019 | Oct 31, 2017 | $288.29M | Dec 19, 2019 |
| FY2018 | Oct 31, 2016 | $259.71M | Dec 20, 2018 |
Capital Expenditures (Capex)
Cash spent on acquiring or upgrading physical assets — property, equipment, and infrastructure. High capex businesses include manufacturing, telecom, and energy companies.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Oct 31, 2025 | $72.89M | Dec 22, 2025 |
| FY2025 | Oct 31, 2024 | $58.26M | Dec 22, 2025 |
| FY2025 | Oct 31, 2023 | $49.43M | Dec 22, 2025 |
| FY2024 | Oct 31, 2022 | $31.98M | Dec 19, 2024 |
| FY2023 | Oct 31, 2021 | $36.18M | Dec 20, 2023 |
| FY2022 | Oct 31, 2020 | $22.94M | Dec 21, 2022 |
| FY2021 | Oct 31, 2019 | $28.94M | Dec 21, 2021 |
| FY2020 | Oct 31, 2018 | $41.87M | Dec 23, 2020 |
| FY2019 | Oct 31, 2017 | $26.00M | Dec 19, 2019 |
| FY2018 | Oct 31, 2016 | $30.86M | Dec 20, 2018 |
Total Assets
The total value of everything the company owns or controls — cash, investments, receivables, property, equipment, and intangibles. Reported as of fiscal year end.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Oct 31, 2025 | $8.50B | Dec 22, 2025 |
| FY2025 | Oct 31, 2024 | $7.59B | Dec 22, 2025 |
| FY2024 | Oct 31, 2023 | $7.20B | Dec 19, 2024 |
| FY2023 | Oct 31, 2022 | $4.10B | Dec 20, 2023 |
| FY2022 | Oct 31, 2021 | $3.50B | Dec 21, 2022 |
| FY2021 | Oct 31, 2020 | $3.55B | Dec 21, 2021 |
| FY2020 | Oct 31, 2019 | $2.97B | Dec 23, 2020 |
| FY2019 | Oct 31, 2018 | $2.65B | Dec 19, 2019 |
| FY2018 | Oct 31, 2017 | $2.51B | Dec 20, 2018 |
| FY2018 | Oct 31, 2016 | $2.00B | Dec 20, 2018 |
Total Liabilities
All financial obligations owed to outside parties — including debt, accounts payable, accrued expenses, and deferred revenue. Subtracting liabilities from total assets gives stockholders' equity.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Oct 31, 2025 | $3.65B | Dec 22, 2025 |
| FY2025 | Oct 31, 2024 | $3.53B | Dec 22, 2025 |
| FY2024 | Oct 31, 2023 | $3.64B | Dec 19, 2024 |
| FY2023 | Oct 31, 2022 | $1.12B | Dec 20, 2023 |
| FY2022 | Oct 31, 2021 | $948.88M | Dec 21, 2022 |
| FY2021 | Oct 31, 2020 | $1.32B | Dec 21, 2021 |
| FY2020 | Oct 31, 2019 | $1.09B | Dec 23, 2020 |
| FY2019 | Oct 31, 2018 | $1.02B | Dec 19, 2019 |
| FY2018 | Oct 31, 2017 | $1.13B | Dec 20, 2018 |
| FY2017 | Oct 31, 2016 | $851.20M | Dec 21, 2017 |
Stockholders Equity
The net worth attributable to shareholders: total assets minus total liabilities. Also called book value. Can be negative if liabilities exceed assets, which is common in capital-intensive industries.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Oct 31, 2025 | $4.31B | Dec 22, 2025 |
| FY2025 | Oct 31, 2024 | $3.64B | Dec 22, 2025 |
| FY2024 | Oct 31, 2023 | $3.15B | Dec 19, 2024 |
| FY2023 | Oct 31, 2022 | $2.61B | Dec 20, 2023 |
| FY2022 | Oct 31, 2021 | $2.26B | Dec 21, 2022 |
| FY2021 | Oct 31, 2020 | $1.98B | Dec 21, 2021 |
| FY2020 | Oct 31, 2019 | $1.67B | Dec 23, 2020 |
| FY2019 | Oct 31, 2018 | $1.40B | Dec 19, 2019 |
| FY2018 | Oct 31, 2017 | $1.16B | Dec 20, 2018 |
| FY2017 | Oct 31, 2016 | $963.38M | Dec 21, 2017 |
Goodwill
An intangible asset representing the premium paid above fair value when acquiring another company. A large goodwill balance signals a history of acquisitions at premium prices.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Oct 31, 2025 | $3.66B | Dec 22, 2025 |
| FY2025 | Oct 31, 2024 | $3.38B | Dec 22, 2025 |
| FY2025 | Oct 31, 2023 | $3.27B | Dec 22, 2025 |
| FY2024 | Oct 31, 2022 | $1.67B | Dec 19, 2024 |
| FY2023 | Oct 31, 2021 | $1.45B | Dec 20, 2023 |
| FY2022 | Oct 31, 2020 | $1.38B | Dec 21, 2022 |
| FY2021 | Oct 31, 2019 | $1.27B | Dec 21, 2021 |
| FY2020 | Oct 31, 2018 | $1.11B | Dec 23, 2020 |
| FY2019 | Oct 31, 2017 | $1.08B | Dec 19, 2019 |
| FY2018 | Oct 31, 2016 | $865.72M | Dec 20, 2018 |
Retained Earnings
Cumulative net income kept by the company rather than distributed as dividends. A growing retained earnings balance indicates consistent profitability; a deficit indicates cumulative losses.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Oct 31, 2025 | $3.65B | Dec 22, 2025 |
| FY2025 | Oct 31, 2024 | $3.06B | Dec 22, 2025 |
| FY2024 | Oct 31, 2023 | $2.61B | Dec 19, 2024 |
| FY2023 | Oct 31, 2022 | $2.25B | Dec 20, 2023 |
| FY2022 | Oct 31, 2021 | $1.95B | Dec 21, 2022 |
| FY2021 | Oct 31, 2020 | $1.69B | Dec 21, 2021 |
| FY2020 | Oct 31, 2019 | $1.40B | Dec 23, 2020 |
| FY2019 | Nov 1, 2018 | $1.10B | Dec 19, 2019 |
| FY2019 | Oct 31, 2018 | $1.09B | Dec 19, 2019 |
| FY2018 | Oct 31, 2017 | $844.25M | Dec 20, 2018 |
Cash & Equivalents
Highly liquid assets the company holds — cash on hand, bank balances, and short-term investments with maturities of three months or less. A key indicator of short-term financial health.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2022 | Oct 31, 2022 | $139.50M | Dec 21, 2022 |
| FY2022 | Oct 31, 2021 | $108.30M | Dec 21, 2022 |
| FY2021 | Oct 31, 2020 | $406.85M | Dec 21, 2021 |
| FY2020 | Oct 31, 2019 | $57.00M | Dec 23, 2020 |
| FY2020 | Oct 31, 2018 | $59.60M | Dec 23, 2020 |
| FY2019 | Oct 31, 2017 | $52.07M | Dec 19, 2019 |
| FY2020 | Oct 31, 2016 | $52.07M | Dec 23, 2020 |
| FY2018 | Oct 31, 2015 | $33.60M | Dec 20, 2018 |
| FY2017 | Oct 31, 2014 | $20.23M | Dec 21, 2017 |
| FY2016 | Oct 31, 2013 | $15.50M | Dec 15, 2016 |
EPS (Basic)
Net income divided by the weighted average shares outstanding. Basic EPS does not account for dilutive securities like options or convertible bonds — use diluted EPS for a more conservative view.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Oct 31, 2025 | 4 | Dec 22, 2025 |
| FY2025 | Oct 31, 2024 | 3 | Dec 22, 2025 |
| FY2025 | Oct 31, 2023 | 2 | Dec 22, 2025 |
| FY2024 | Oct 31, 2022 | 2 | Dec 19, 2024 |
| FY2023 | Oct 31, 2021 | 2 | Dec 20, 2023 |
| FY2020 | Oct 31, 2020 | 0 | Dec 23, 2020 |
| FY2020 | Jul 31, 2020 | 0 | Dec 23, 2020 |
| FY2020 | Apr 30, 2020 | 0 | Dec 23, 2020 |
| FY2020 | Jan 31, 2020 | 0 | Dec 23, 2020 |
| FY2020 | Oct 31, 2019 | 0 | Dec 23, 2020 |
EPS (Diluted)
Net income divided by the fully diluted share count — including all potential shares from options, warrants, and convertible instruments. The more conservative and widely cited EPS figure.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Oct 31, 2025 | 4 | Dec 22, 2025 |
| FY2025 | Oct 31, 2024 | 3 | Dec 22, 2025 |
| FY2025 | Oct 31, 2023 | 2 | Dec 22, 2025 |
| FY2024 | Oct 31, 2022 | 2 | Dec 19, 2024 |
| FY2023 | Oct 31, 2021 | 2 | Dec 20, 2023 |
| FY2020 | Oct 31, 2020 | 0 | Dec 23, 2020 |
| FY2020 | Jul 31, 2020 | 0 | Dec 23, 2020 |
| FY2020 | Apr 30, 2020 | 0 | Dec 23, 2020 |
| FY2020 | Jan 31, 2020 | 0 | Dec 23, 2020 |
| FY2020 | Oct 31, 2019 | 0 | Dec 23, 2020 |
Shares Outstanding
Total common shares issued and held by all shareholders, excluding treasury shares. Combined with market price gives market capitalization.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2020 | Oct 31, 2020 | 54.20M | Dec 23, 2020 |
| FY2020 | Oct 31, 2019 | 54.14M | Dec 23, 2020 |
| FY2019 | Oct 31, 2018 | 53.36M | Dec 19, 2019 |
| FY2018 | Oct 31, 2017 | 52.78M | Dec 20, 2018 |
| FY2017 | Oct 31, 2016 | 33.72M | Dec 21, 2017 |
| FY2016 | Oct 31, 2015 | 26.91M | Dec 15, 2016 |
| FY2015 | Oct 31, 2014 | 26.85M | Dec 17, 2015 |
| FY2011 | Oct 31, 2011 | 17.05M | Dec 22, 2011 |
| FY2011 | Oct 31, 2010 | 16.41M | Dec 22, 2011 |
| FY2010 | Oct 31, 2009 | 13.01M | Dec 22, 2010 |
Dividends Paid
Cash dividends distributed to common shareholders during the period. Shown as a positive value despite being a cash outflow in the SEC filing.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Oct 31, 2025 | $31.97M | Dec 22, 2025 |
| FY2025 | Oct 31, 2024 | $29.07M | Dec 22, 2025 |
| FY2025 | Oct 31, 2023 | $27.37M | Dec 22, 2025 |
| FY2024 | Oct 31, 2022 | $24.47M | Dec 19, 2024 |
| FY2023 | Oct 31, 2021 | $23.00M | Dec 20, 2023 |
| FY2022 | Oct 31, 2020 | $21.55M | Dec 21, 2022 |
| FY2021 | Oct 31, 2019 | $18.69M | Dec 21, 2021 |
| FY2020 | Oct 31, 2018 | $15.36M | Dec 23, 2020 |
| FY2019 | Oct 31, 2017 | $12.81M | Dec 19, 2019 |
| FY2018 | Oct 31, 2016 | $10.72M | Dec 20, 2018 |